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Evidence-based medicine is switching from the analysis of single diseases at a time toward an integrated
assessment of a diseased person. Complementary and alternative medicine (CAM) offers multiple hol-
istic approaches, including osteopathy, homeopathy, chiropractic, acupuncture, herbal and energy medi-
cine and meditation, all potentially impacting on major human diseases. It is now becoming evident that
acupuncture can modify the expression of different endorphin genes and the expression of genes encod-
ing for crucial transcription factors in cellular homeostasis. Extremely low frequency magnetic fields
have been found to prime the commitment to a myocardial lineage in mouse embryonic stem cells, sug-
gesting that magnetic energy may direct stem cell differentiation into specific cellular phenotypes with-
out the aid of gene transfer technologies. This finding may pave the way to novel approaches in tissue
engineering and regeneration. Different ginseng extracts have been shown to modulate growth and dif-
ferentiation in pluripotent cells and to exert wound-healing and antitumor effects through opposing
activities on the vascular system, prompting the hypothesis that ancient compounds may be the target
for new logics in cell therapy. These observations and the subtle entanglement among different CAM
systems suggest that CAM modalities may deeply affect both the signaling and transcriptional level of
cellular homeostasis. Such a perception holds promises for a new era in CAM, prompting reproducible
documentation of biological responses to CAM-related strategies and compounds. To this end, func-
tional genomics and proteomics and the comprehension of the cell signaling networks may substantially
contribute to the development of a molecular evidence–based CAM.
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Introduction
Complementary and alternative medicine (CAM) is emerging
as a heterogeneous subject encompassing wide-ranging hol-
istic approaches to a diseased human being that include herbal
medications, aromatherapy, acupuncture, yoga, tai chi and
magnetic energy (1–4). Despite modern technology and
chemistry, a number of chronic, degenerative and malignant
diseases remain incurable by current western medicine.
Coupled to this fact is an awareness that even the most recent
therapeutic armamentarium provided by western medicine is
still remarkably crude compared with the finely tuned com-
plexity of biological systems. It is now becoming increasingly
evident that such complexity is fashioned at multiple intercon-
nected levels and is controlled by an interplay between cell
signaling, gene expression, nucleosomal assembly, the estab-
lishment of multifaceted transcriptional motifs and the
temporal and spatial organization of chromatin in loops and
domains. Moreover, recently developed nanoscale science
and technology interventions are providing a remarkable
glimpse into how living organisms may organize nanoarchitec-
tonics at a hierarchical level of assembly to produce specific
cellular phenotypes and functions. Within this context, ancient
practices have been revisited as CAM tools potentially impact-
ing on major human diseases, and old compounds from tradi-
tional Chinese medicine have been shown to have features
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and tissue repair.
These findings hold promises for a new era in CAM and
raise the need for reproducible documentation of biological
responses to CAM-related strategies and compounds (5).
Such a dissection may require novel holistic experimental
approaches in molecular biology and medicine involving an
interconnected analysis of functional genomics and proteo-
mics and an integrated comprehension of the underlying
signal-transduction mechanisms.
The development of suitable in vitro and in vivo experi-
mental models is now perceived as a crucial requirement in
CAM. Nevertheless, a consistent number of CAM modalities
are still awaiting more functional and molecular approaches
that may further underpin CAM systems.
So far, a detailed analysis of cell signaling networks and
gene expression patterning has been carried out for a limited
number of CAM strategies, including acupuncture, the use of
magnetic energy and targeted compounds from herbal medi-
cine. This review is focused on the discussion of intriguing
findings achieved in these fields with the aid of molecular
and cellular biology approaches, showing that CAM may be
much more profound than conventional science has hitherto
been prepared to admit.
Acupuncture and Gene Expression
Growing evidence indicates a close relationship between the
application of acupuncture and the modulation of endorphiner-
gic systems. One of the most surprising and fascinating
insights in recent analysis of the interplay among these systems
and acupuncture is the finding that this treatment is able to eli-
cit remarkable changes in the expression of specific endorphin
genes. Experimental studies performed in rats revealed that
2 and 100 Hz acupuncture primed consistent changes in brain
expression of the three opioid genes proopiomelanocortin, pre-
proenkephalin and prodynorphin (6). The spatial and temporal
patterns of these changes varied in a frequency-dependent
fashion. In particular, 2 Hz electroacupuncture mainly
increased preproenkephalin gene expression without affecting
the expression of the prodynorphin gene, which was in turn
selectively increased following a 100 Hz treatment (6). In dif-
ferent experimental animal models, electroacupuncture was
also found to increase brain expression of the c-fos and c-jun
genes, as well as the expression of their related protein pro-
ducts (7–9). This is particularly rewarding since Fos is an
important transcription factor selectively recognizing opioid
gene promoters. Moreover, Jun and Fos are known to establish
productive interactions leading to the formation of heterodi-
mers, acting as strong transactivating complexes for genes
playing a crucial role in cellular homeostasis. Within this con-
text, concerted activation of Fos/Jun expression by electroacu-
puncture emerged as a molecular mechanism underlying the
selective increase in prodynorphin gene expression as com-
pared with the expression of the preproenkephalin gene (10).
These effects were blocked by antisense oligonucleotides
directed against c-fos and c-jun (10), suggesting that acupunc-
ture may regulate gene expression by selectively affecting
transcription factor assembly into specific multifunctional
transcriptional complexes.
With respect to the cardiovascular system, application of
5 Hz electroacupunture at the level of the median nerves in
rats proved effective in reducing myocardial ischemia and
contractile dysfunctions provoked by partial experimental
occlusion of the left anterior descending coronary artery or fol-
lowing ligation of its diagonal branch (11). In this experi-
mental model, bradykinin was applied to the gallbladder to
further impair myocardial dynamics, eliciting a number of
reflex responses, including increases in left ventricular dP/dt,
coronary blood velocity and myocardial oxygen demand
(11). Under these experimental conditions, naloxone, a select-
ive opioid receptor antagonist, was found to counteract the
protective effects induced by electroacupuncture (12). These
results indicate that even the cardiovascular responses elicited
by acupuncture may be mediated, at least in part, by the activa-
tion of endorphinergic mechanisms.
These observations and the ability of acupuncture to activate
endorphin gene expression and signaling may have further bio-
medical implications. It is now clear that endorphins play an
important role in ischemic preconditioning, a mechanism
through which myocardial tissue exposed to repeated minor
ischemic events acquires substantial protection against a major
ischemic insult. Such a view is supported by a number of inter-
related observations. First, in freshly isolated adult rabbit car-
diomyocytes subjected to simulated ischemia, cell death was
remarkably prevented by dynorphin B, an endogenous kappa
opioid receptor agonist, and by the synthetic ligand of delta
receptors Met5-enkephalin. Such an effect was specific in
nature and involved sarcolemmal and mitochondrial ATP-
sensitive K
þ channels (13). Second, the cardioprotective bene-
fits of ischemic preconditioning can be transferred from
preconditioned to virgin acceptor hearts via coronary effluent
transfusion, implying the presence of hormonal precondition-
ing factor(s) (14). In this study, material released into the cor-
onary effluent of isolated buffer-perfused rabbit hearts during
preconditioned ischemia/reperfusion or normoxic perfusion
was concentrated by reverse phase chromatography. Treat-
ment with preconditioned concentrate but not with normoxic
effluent evoked cardioprotection equivalent to that afforded
by conventional preconditioning (14). Naloxone nullified the
protection achieved by transfer of preconditioned concentrate.
These results indicate that coronary effluent from precondi-
tioned hearts evokes a cardioprotective effect via a mechanism
requiring an intact opioid receptor system (14). Third, in
isolated perfused rat hearts the stimulation of kappa opioid
receptors with the synthetic agonist U-50488H not only
reduced the size of the infarct induced by ischemia, mimicking
the protective effect of ischemic preconditioning, but elicited a
significant amelioration of ischemia-induced arrhythmias (15).
In this light, acupuncture may be viewed as a therapeutic
system considerably more complex than expected since its
effects on crucial organs and apparatuses may involve a deep
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the cellular level (Fig. 1). A large body of experimental
studies in suitable in vivo and in vitro models should be envi-
sioned to assess the molecular basis of acupuncture-evoked
responses.
Magnetic Fields and Stem Cell Differentiation:
A Novel Frontier in Phenotyping Design
Magnetic fields (MFs) have been shown to affect proliferation
and growth factor expression in cultured cells (16–18) and to
interfere with endorphinergic and cholinergic systems in intact
organisms (19–21). MFs have been found to induce increased
levels of hsp70, affording cytoprotection in different cell types
(22), and have been reported to promote bone formation and to
repair augmenting fracture and post-surgery healing (23,24).
Nevertheless, the possibility that the activation of a coordin-
ated program of cell differentiation or the specification of a
cellular architectural plan may represent the molecular under-
pinning of the MF effect has long awaited compelling experi-
mental evidence. We have previously shown that exposure to
extremely low frequency MFs increased the expression of the
prodynorphin gene, encoding for the dynorphin family of
opioid peptides, in adult rat ventricular cardiomyocytes (25).
This effect was associated with the synthesis and secretion of
dynorphin B (25), a bioactive gene product selectively acting
on kappa opioid receptors coupled to phosphoinositide turn-
over, and regulation of cytosolic calcium homeostasis and
contractility in the myocardial cell (26–28). It is now clear
that endorphins may behave as growth factors remarkably
affecting cell growth and differentiation. To this end, we
have also provided evidence that dynorphin B primed cardiac
differentiation in embryonal carcinoma cells (29) and that a
dynorphinergic system acted as a major conductor of cardio-
genesis in multipotent mouse embryonic stem (ES) cells
(30,31). Based on these findings we have recently investigated
whether MF may be able to trigger endorphin gene expression
even in ES cells and whether, if so, MF may commit these cells
to the specification of a targeted lineage. For this purpose,
mouse ES cells were exposed to a sinusoidal MF (50 Hz,
0.8 mT rms) generated by a system consisting of two identical
apparatuses each bearing four coaxial circular coils placed
horizontally in a commercial CO2 incubator, and thus parallel
with respect to the surface of the culture well plates. The geo-
metry of the coil system was numerically calculated in order to
optimize the extension of the MF uniformity. Each coil was
wound by a pair of parallel wires so that, according to different
connections, the current could flow either in the same direction
(‘wound configuration’), generating the active exposure, or in
the opposite direction (‘counter-wound configuration’), allow-
ing a sham exposure. During the experiments, performed
blind, the temperature was monitored by means of a thermo-
resistor. The local geomagnetic (45 mT) field was measured
using a gaussmeter (F.W.Bell 7010) and the AC background
MF (0.05 mT) by means of a sensitive probe (EMDEXII,
Enertech).
Under these experimental conditions, ES cell exposure to
MF was found to increase remarkably the expression of genes
encoding for tissue-restricted transcription factors (Fig. 2),
determining a consistent upregulation of GATA-4 and Nkx-
2.5 mRNA (32). These genes encode respectively for a zinc
finger containing transcription factor and a homeodomain
Figure 1. Putative signaling networks encompassed by CAM strategies.
Increasing evidence indicates that acupuncture leads to the expression of
c-fos and c-jun genes and their related protein products, which act as growth
regulatory transcription factors. Concerted activation of Fos/Jun expression
by electroacupuncture has emerged as a molecular mechanism underlying
the increase in the expression of targeted endorphin genes. Additionally, old
nutraceuticals commonly used in Chinese traditional medicine have been
found to have the potential for differentiating logics, acting on cell renewal
and lineage commitment in pluripotent cells. Exposure to magnetic energy
may ultimately result in the activation of signaling network(s) previously
believed to be activated solely in the presence of a growth factor. Future direc-
tions may involve the analysis of CAM-related approaches within the context
of the molecular examination of a number of signal-transduction mechanisms,
including the activation of selected G-protein coupled receptors and the inter-
play between the subcellular redistribution patterning of defined kinase
isozymes and the activation of tissue-restricted transcription factors (a
representative scheme of a tyrosine receptor kinase signaling is shown). The
analysis of long-lived signals, involving the establishment of autocrine feed-
forward circuits, should also be envisioned.
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different animal species (33,34), including humans (35). MF
also enhanced prodynorphin mRNA expression and the levels
of dynorphin B in both embryoid bodies (EBs) and ES-derived
cardiomyocytes and in their incubation media (32). This find-
ing is particularly rewarding since we have shown that the
prodynorphin gene and dynorphin B primed GATA-4 and
Nkx-2.5 transcription (29,30) and triggered protein kinase C
(PKC) signaling through complex subcellular redistribution
patterning of targeted PKC isozymes, another major require-
ment for ES cell commitment to the cardiac lineage (30). Addi-
tionally, dynorphin B was found to act as an agonist of nuclear
opioid receptors coupling nuclear PKC activation to the tran-
scription of cardiogenic genes, indicating that intracrine
signals for cardiac differentiation may also be fashioned by
the prodynorphin gene and its related peptides (31). Interest-
ingly, nuclear run-off analyses performed in isolated ES nuclei
indicated that the MF action occurred at the transcriptional
level (32). The activation of a program of cardiogenic gene
transcription was also associated with an increase in the
expression of the cardiac-specific transcripts a-myosin heavy
chain and myosin light chain-2V (Fig. 2). On the whole, these
transcriptional responses elicited a significant increase in the
number of spontaneously beating cardiomyocytes, indicating
that exposure to an MF resulted in a major enhancement of
the cardiogenic potential of pluripotent stem cells (32). Note-
worthy in this study is the fact that the expression of MyoD,
a gene involved in skeletal myogenesis, was not affected in
either EBs or ES-derived cardiomyocytes. On the contrary,
the expression of neurogenin1, a neuronal specification
gene, was slightly enhanced only in EBs. These observations
exclude a generalized activation of repressed genes and
suggest that coupling of MF with GATA-4, Nkx-2.5 and
prodynorphin gene expression may represent a mechanism
pertaining to ES cell cardiogenesis.
It has recently been proposed that stem cells are a novel tool
for cellular therapy of damaged tissues. Unfortunately, their
rescuing potential is limited by the fact that differentiating
cells withdraw early from the cell cycle. Hence, the develop-
ment of strategies affording high throughput of targeted lin-
eages from pluripotent cells would have obvious biomedical
implications. However, overexpression of tissue-specific
genes by vector-mediated gene transfer to gain a high through-
put of targeted lineages from pluripotent cells is a cumbersome
approach that may perturb normal homeostasis in both stem
cells and recipient tissues, and it is not readily envisionable
in humans.
The observation that cell fate may be orchestrated by MF
opens the new perspective of using magnetic energy to direct
the differentiation processes of stem cells into a specific
cellular phenotype without the aid of gene transfer technolo-
gies. These findings also prompt future investigations to
shed additional light on the molecular events underlying the
differentiating response primedby MF inES cells and to assess
whether such a response may be dependent on the field
characteristics, including MF intensity, frequency and wave
shape (signaling networks hypothetically encompassed by
MF-related dynamics are depicted in Fig. 1).
Ginseng and Cell Fate Patterning:
Old Molecules and New Logics
Ginseng is a commonly used nutraceutical. Mass spectromet-
ric compositional analysis of American, Chinese, Korean and
Sanqi ginseng revealed distinct ‘sterol ginsenoside’ finger-
prints, especially in the ratio between a triol, Rg1, and a diol,
Figure 2. Stem cell exposure to magnetic energy leads to targeted lineage specification. As shown in the diagram, exposure of undifferentiated mouse embryonic
stem cells (GTR1 cell line) to extremely low frequency magnetic fields primes the transcription of cardiac lineage promoting genes and the synthesis and secretion
of dynorphin B, acting as an orchestrator of signaling and gene expression patterning required for the appearance of a myocardial phenotype (for details see the
section ‘Magnetic fields and stem cell differentiation: a novel frontier in phenotyping design’). Cardiomyocytes (lower panel) express cardiac-specific markers,
including a-myosin heavy chain (a-MHC) and myosin light chain-2V (MLC). (a-MHC is stained green with the MF 20 mouse antimyosin monoclonal antibody;
DNA is visualized with prospidium iodide. Bio-Rad Microradians confocal microscope, ·20 objective.)
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Rg1 was shown to promote proliferation of hippocampal
progenitor cells (37). Ginsenosides Rh1 and Rh2 were found
to induce differentiation of embryonal carcinoma cells in
endoderm-like cells (38). This effect was prevented by a
glucocorticoid receptor (GR) antagonist, and protein factors
capable of specifically binding to the glucocorticoid respons-
ive element (GRE) were detected in nuclear extracts of the
ginsenoside-treated cells. Moreover, overexpression of GR
by co-transfection of a GR expression vector and a GRE-
luciferase vector enhanced the transactivation activity of the
GRE promoter in the presence of the two different ginsenos-
ides (38). The existing literature reports both wound-healing
and antitumor effects of ginseng extracts through opposing
activities on the vascular system. Using a Matrigel implant
model and reconstituting the extracts with the aid of distinct
ratios of the two ginsenosides Rg1 and Rg2, the dominance
of Rg1 has been recently found to promote angiogenesis,
whereas Rb1 exerted an opposing effect (36). Rg1 also elicited
functional neovascularization into a polymer scaffold in vivo
and the proliferation, chemoinvasion and tubulogenesis of
endothelial cells in vitro (36). In contrast, Rb1 inhibited
the earliest step in angiogenesis, the chemoinvasion of
endothelial cells. The pro-angiogenic effects of Rg1 involved
the expression of nitric oxide synthase (NOS) and the
phosphatidylinositol-3 kinase-Akt pathway (36). Intriguingly,
besides its crucial role in neovascularization, endothelial
NOS is expressed by bone marrow stromal cells and has
been found to be essential in the recruitment of stem and pro-
genitor cells (39). It has been proposed that this contributes
to impaired regeneration processes in ischemic heart disease
patients, who are characterized by a reduced systemic NO bio-
activity. In this regard, both inducible and endothelial NOS
isoforms are prominently expressed during early stages of
cardiomyogenesis and NO generation is required for cardio-
myogenesis, since NOS inhibitors prevent the maturation of
terminally differentiated cardiomyocytes in in vitro ES cell
systems (40). The ability of ginsenosides to activate Akt sig-
naling is also worthy of consideration. Within this context,
transplantation of rat mesenchymal stem cells genetically
engineered to overexpress Akt into the ischemic rat myocar-
dium inhibited the process of cardiac remodeling by reducing
intramyocardial inflammation, collagen deposition and cardiac
myocyte hypertrophy (41). Akt-overexpressing cells regener-
ated 80–90% of lost myocardial volume and completely
normalized systolic and diastolic cardiac function (41). Thus,
mesenchymal stem cells genetically enhanced with Akt can
repair infarcted myocardium, prevent remodeling and nearly
normalize cardiac performance.
Transplantation of adult bone marrow–derived mesen-
chymal stem cells has been proposed as a strategy for cardiac
repair following myocardial damage (42). However, poor cell
viability associated with transplantation has limited the repar-
ative capacity of these cells in vivo. In this light, chemical and
signaling features from ginsenosides prompt the hypothesis
that ginseng may contain potential differentiating molecules
that have a role in cardiovascular rescue. Further studies invol-
ving molecular and cellular biology approaches and compel-
ling in vivo validation are needed to address these issues. If
the results are positive, an ancient compound may be the target
for new logics in cell therapy and tissue engineering. (Fig. 1
traces working hypotheses on signaling and transcriptional
patterning that may be investigated to uncover the molecular
underpinning for the effects elicited by ginsenosides and
other potential morphogenetic agents isolated from herbal
compounds.)
Wide-Ranging Transcriptional Profiling of
CAM Responses: From Holistic Medicine to
Holistic Molecular Biology
The analysis of the experimental findings discussed in this
review indicates that many CAM modalities may be impacting
the transcriptional level of cell functioning and may be further
exploited by genomic means. However, conventional tech-
niques, including RT–PCR, northern blotting and RNase pro-
tection, allow the analysis of the expression of only a few
genes at a time. Moreover, these techniques imply a selection
‘a priori’ of putative candidate genes intervening in the invest-
igated responses, providing only a partial picture with no direct
information about the abundance and timely patterning of
transcriptional events.
The recent development of novel DNA nanotechnologies
such as the serial analysis of gene expression (SAGE) and
DNA microarrays has allowed a rapid and detailed analysis
of thousands of transcripts, providing a revolutionary approach
to the investigation of gene expression. SAGE is a nanoscale
DNA biotechnology essentially based on two principles (43).
First, a short nucleotide sequence tag of 9 bp contains suffi-
cient information to uniquely identify a transcript, provided
it is isolated from a defined position within the transcript.
Second, concatenation of short sequence tags to form a ‘con-
catemer’ allows the efficient analysis of transcripts in a serial
manner by the sequencing of multiple tags within a single
clone. The sequence of the clones will allow the development
of a profile for the gene expression. Quantitative data regard-
ing the prevalence of an expressed gene will be derived from
the frequency with which a given tag is found. To this end,
the SAGE approach has led to the awareness of multiple
gene expression patterning within a given experimental time
course. Furthermore, new transcripts corresponding to novel
tags have been identified.
Another experimental approach that can be used for multiple
gene expression profiling is the DNA chip (44). In this method,
oligonucleotides corresponding to candidate genes are
deposited onto a glass surface to construct a DNA microarray.
Fluorescent cDNAs are prepared from the different mRNA
sources with the use of reverse transcriptase in the presence
of fluoresceine- and lissamine-labeled nucleotide analogs.
One set of cDNA is from the control sample and the other
from the sample in which differential gene expression is being
eCAM 2005;2(3) 281examined. The two fluorescent cDNAs are then allowed to
hybridize to the DNA microarray and a pattern of fluorescence
is detected by separately scanning the fluorescence emitted
from excited fluoresceine and lissamine. Fluorescence analysis
is ultimately used to monitor simultaneously both the overex-
pression and the downregulation of multiple genes within
each sample investigated.
The use of these techniques in the analysis of large-scale
transcriptional profiling is still at an early stage. However, it
is conceivable that in the next few years these novel strategies
may help to understand how the intricate machinery of
gene expression is driven by the interplay of different signal-
transduction pathways.
Evidence-based medicine is progressively switching from a
strategy involving the assessment of single diseases at a time
to a holistic approach centered on a diseased person, thereby
recognizing a fundamental strategy that has long been estab-
lished and validated in CAM. The identity of gene expression
profiles potentially involved in a large number of CAM-related
responses remains mostly enigmatic. The potential application
of SAGE and DNA microarrays to CAM systems may con-
ceivably lead to the identification and characterization of
genes and signaling pathways that are involved in CAM mod-
alities, thrusting forward further exploration of the role of
selected identified genes in suitable animal models.
CAM disciplines, owing to their holistic nature, have long
been thought to be far from influencing DNA dynamics and
the molecular plight(s) of cell functioning. The findings dis-
cussed in the present review may therefore appear quite
revolutionary for CAM and suggest that the CAM literature
may shortly encompass a number of discoveries attained by
the aid of conventional science techniques.
These perceptions and the future directions suggested by
molecular genomics may offer a crucial contribution to the
development of a molecular evidence–based CAM.
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